Balyasny Asset Management L.P. decreased its position in shares of Innovex International, Inc. (NYSE:INVX - Free Report) by 83.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 62,424 shares of the company's stock after selling 315,126 shares during the quarter. Balyasny Asset Management L.P. owned approximately 0.09% of Innovex International worth $872,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. KLP Kapitalforvaltning AS purchased a new stake in Innovex International during the 4th quarter worth about $88,000. Oregon Public Employees Retirement Fund lifted its holdings in Innovex International by 9.4% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 8,852 shares of the company's stock worth $124,000 after purchasing an additional 758 shares in the last quarter. Aigen Investment Management LP purchased a new stake in Innovex International during the 4th quarter worth about $142,000. Amalgamated Bank lifted its holdings in Innovex International by 6.2% during the 4th quarter. Amalgamated Bank now owns 10,853 shares of the company's stock worth $152,000 after purchasing an additional 630 shares in the last quarter. Finally, Maryland State Retirement & Pension System lifted its holdings in Innovex International by 9.0% during the 4th quarter. Maryland State Retirement & Pension System now owns 12,681 shares of the company's stock worth $177,000 after purchasing an additional 1,047 shares in the last quarter.
Analysts Set New Price Targets
Separately, Barclays dropped their price objective on Innovex International from $16.00 to $13.00 and set an "underweight" rating on the stock in a report on Friday, May 9th.
Read Our Latest Stock Report on Innovex International
Innovex International Stock Up 0.2%
INVX traded up $0.03 during trading on Friday, reaching $14.98. 317,639 shares of the company were exchanged, compared to its average volume of 407,450. The company has a 50-day simple moving average of $16.14. The stock has a market cap of $1.03 billion, a P/E ratio of 10.62 and a beta of 0.80. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.17 and a current ratio of 3.87. Innovex International, Inc. has a 12-month low of $11.93 and a 12-month high of $19.51.
Innovex International (NYSE:INVX - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.29 earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.03). Innovex International had a net margin of 12.31% and a negative return on equity of 0.73%. The business had revenue of $240.42 million during the quarter, compared to analysts' expectations of $247.73 million.
Innovex International Company Profile
(
Free Report)
Innovex International, Inc engages in the provision of solutions for both onshore and offshore applications within the oil and gas industry. The company was founded on September 15, 2016 and is headquartered in Humble, TX.
Read More

Before you consider Innovex International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innovex International wasn't on the list.
While Innovex International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.